comparemela.com
Home
Live Updates
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and ... : comparemela.com
Apellis Announces Negative CHMP Opinion for Pegcetacoplan for GA in the European Union and ...
WALTHAM, Mass., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency
Related Keywords
United States ,
Americans ,
Lissa Pavluk ,
Jeffrey Eisele ,
Meredith Kaya ,
Twitter ,
Committee For Medicinal Products Human Use ,
Lancet Glob Health ,
Research Group ,
Apellis Pharmaceuticals Inc ,
Exchange Commission ,
Nasdaq ,
Exchange Commission On ,
European Medicines Agency ,
Linkedin ,
Medicinal Products ,
Human Use ,
Geographic Atrophy ,
Forward Looking Statement ,
Private Securities Litigation Reform Act ,
Apelli Annual Report ,
Quarterly Report ,
Region ,
comparemela.com © 2020. All Rights Reserved.